Value Assessment of Orphan Drugs and Treatments for Rare Diseases

Summary

Value Assessment of Orphan Drugs and Treatments for Rare Diseases is a written work^[1].

Key Facts

• Value Assessment of Orphan Drugs and Treatments for Rare Diseases authored Catherine M Lockhart^[2].
• Value Assessment of Orphan Drugs and Treatments for Rare Diseases's instance of is recorded as written work^[3].
• Value Assessment of Orphan Drugs and Treatments for Rare Diseases's instance of is recorded as master's thesis^[4].
• Value Assessment of Orphan Drugs and Treatments for Rare Diseases's OCLC number is recorded as 954774773^[5].
• Value Assessment of Orphan Drugs and Treatments for Rare Diseases's language of work or name is recorded as English^[6].
• +2016-00-00T00:00:00Z marks the founding of Value Assessment of Orphan Drugs and Treatments for Rare Diseases^[7].
• Value Assessment of Orphan Drugs and Treatments for Rare Diseases's work available at URL is recorded as http://hdl.handle.net/1773/36455^[8].
• Value Assessment of Orphan Drugs and Treatments for Rare Diseases's Handle ID is recorded as 1773/36455^[9].
• Value Assessment of Orphan Drugs and Treatments for Rare Diseases's title is recorded as Value Assessment of Orphan Drugs and Treatments for Rare Diseases^[10].
• Value Assessment of Orphan Drugs and Treatments for Rare Diseases's thesis submitted to is recorded as University of Washington^[11].
• Value Assessment of Orphan Drugs and Treatments for Rare Diseases's on focus list of Wikimedia project is recorded as WikiProject PCC Wikidata Pilot/University of Washington^[12].
• Value Assessment of Orphan Drugs and Treatments for Rare Diseases's thesis committee member is recorded as Ryan N Hansen^[13].

Body

Designation and Status

Recorded instance of include written work^[3] and master's thesis^[4].

History and Context

+2016-00-00T00:00:00Z marks the founding of Value Assessment of Orphan Drugs and Treatments for Rare Diseases^[7].